Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.

Manns M, Samuel D, Gane EJ, et al. Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Lancet Infect Dis. 2016;16(6):685-697.

Publication Type:

Journal Article

Authors:

Manns, M.; Samuel, D.; E J Gane; et, al

Source:

Lancet Infect Dis, Volume 16, Issue 6, p.685-697 (2016)

Cited On:

Export Citation:
RIS Format
Top